國立虎尾科技大學 |

Discoidin domain receptors in health and disease

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Discoidin domain receptors in health and disease/ edited by Rafael Fridman, Paul H. Huang.
other author:	Fridman, Rafael.
Published:	New York, NY :Springer New York : : 2016.,
Description:	xiv, 355 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Cell receptors. -
Online resource:	http://dx.doi.org/10.1007/978-1-4939-6383-6
ISBN:	9781493963836

Discoidin domain receptors in health and disease
Discoidin domain receptors in health and disease[electronic resource] /edited by Rafael Fridman, Paul H. Huang. - New York, NY :Springer New York :2016. - xiv, 355 p. :ill. (some col.), digital ;24 cm.

Part I: Discoidin Domain Receptor biology and roles in physiology -- DDRs: Binding properties, cell adhesion and modulation of integrin function -- DDRs and collagen fibrillogenesis -- DDR Structural Biology -- DDR Mouse models -- DDR in Invertebrates -- Part II: Discoidin Domain Receptors in Cancer -- Discoidin Domain Receptors and Disease -- Discoidin Domain Receptors in Normal Mammary Development and Breast Cancer Progression -- Discoidin Domain Receptors in Lung Cancer -- DDRs in healthy and cancerous reproductive systems -- Small Molecule Inhibitors of Discoidin Domain Receptors -- Discoidin Domain Receptor Signaling Networks -- Discoidin Domain Receptor Signaling and Pharmacological Inhibitors -- Functions of DDR1 in epithelial cell differentiation -- Part III: Discoidin Domain Receptors in other pathologies -- Discoidin Domain Receptor 2 in Development of Osteoarthritis -- DDR1 in Renal Function and Disease -- Discoidin Domain Receptors in Liver Fibrosis -- The role of DDRs in Atherosclerosis -- Discoidin Domain Receptors in Cardiac Development.

The interactions of cells with their surrounding extracellular matrix (ECM) plays a pivotal role in driving normal cell behavior, from development to tissue differentiation and function. At the cellular level, organ homeostasis depends on a productive communication between cells and ECM, which eventually leads to the normal phenotypic repertoire that characterize each cell type in the organism. A failure to establish these normal interactions and to interpret the cues emanating from the ECM is one of the major causes in abnormal development and the pathogenesis of multiple diseases. To recognize and act upon the biophysical signals that are generated by the cross talk between cells and ECM, the cells developed specific receptors, among them a unique set of receptor tyrosine kinases (RTKs), known as the Discoidin Domain Receptors (DDRs) The DDRs are the only RTKs that specifically bind to and are activated by collagen, a major protein component of the ECM. Hence, the DDRs are part of the signaling networks that translate information from the ECM, and thus they are key regulators of cell-matrix interactions. Under physiological conditions, DDRs control cell and tissue homeostasis by acting on collagen sensors; transducing signals that regulate cell polarity, tissue morphogenesis, cell differentiation, and collagen deposition. DDRs play a key role in diseases that are characterized by dysfunction of the stromal component, which lead to abnormal collagen deposition and the resulting fibrotic response that disrupt normal organ function in disease of the cardiovascular system, lungs and kidneys, just to mention a few. In cancer, DDRs are hijacked by tumor and stromal cells to disrupt normal cell-collagen communication and initiate pro-oncogenic programs. Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function, and contribute to cancer progression. Therefore, the strong causative association between altered RTK function and disease it is been translated today in the development of specific tyrosine kinase inhibitors targeting DDRs for various disease conditions. In spite of the accumulating evidence highlighting the importance of DDRs in health and diseases, there is still much to learn about these unique RTKs, as of today there is a lack in the medical literature of a book dedicated solely to DDRs. This is the first comprehensive volume dedicated to DDRs, which will fill a gap in the field and serve those interested in the scientific community to learn more about these important receptors in health and disease.

ISBN: 9781493963836

Standard No.: 10.1007/978-1-4939-6383-6doiSubjects--Topical Terms:

668471
Cell receptors.

LC Class. No.: QH603.C43

Dewey Class. No.: 572.696

Discoidin domain receptors in health and disease
LDR:04642nam a2200313 a 4500 001 866136
003 DE-He213
005 20160813155359.0
006 m d
007 cr nn 008maaau
008 170720s2016 nyu s 0 eng d
020 $a 9781493963836 $q (electronic bk.)
020 $a 9781493963812 $q (paper)
024 7 $a 10.1007/978-1-4939-6383-6 $2 doi
035 $a 978-1-4939-6383-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QH603.C43
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 572.696 $2 23
090 $a QH603.C43 $b D611 2016
245 0 0 $a Discoidin domain receptors in health and disease $h [electronic resource] / $c edited by Rafael Fridman, Paul H. Huang.
260 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2016.
300 $a xiv, 355 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I: Discoidin Domain Receptor biology and roles in physiology -- DDRs: Binding properties, cell adhesion and modulation of integrin function -- DDRs and collagen fibrillogenesis -- DDR Structural Biology -- DDR Mouse models -- DDR in Invertebrates -- Part II: Discoidin Domain Receptors in Cancer -- Discoidin Domain Receptors and Disease -- Discoidin Domain Receptors in Normal Mammary Development and Breast Cancer Progression -- Discoidin Domain Receptors in Lung Cancer -- DDRs in healthy and cancerous reproductive systems -- Small Molecule Inhibitors of Discoidin Domain Receptors -- Discoidin Domain Receptor Signaling Networks -- Discoidin Domain Receptor Signaling and Pharmacological Inhibitors -- Functions of DDR1 in epithelial cell differentiation -- Part III: Discoidin Domain Receptors in other pathologies -- Discoidin Domain Receptor 2 in Development of Osteoarthritis -- DDR1 in Renal Function and Disease -- Discoidin Domain Receptors in Liver Fibrosis -- The role of DDRs in Atherosclerosis -- Discoidin Domain Receptors in Cardiac Development.
520 $a The interactions of cells with their surrounding extracellular matrix (ECM) plays a pivotal role in driving normal cell behavior, from development to tissue differentiation and function. At the cellular level, organ homeostasis depends on a productive communication between cells and ECM, which eventually leads to the normal phenotypic repertoire that characterize each cell type in the organism. A failure to establish these normal interactions and to interpret the cues emanating from the ECM is one of the major causes in abnormal development and the pathogenesis of multiple diseases. To recognize and act upon the biophysical signals that are generated by the cross talk between cells and ECM, the cells developed specific receptors, among them a unique set of receptor tyrosine kinases (RTKs), known as the Discoidin Domain Receptors (DDRs) The DDRs are the only RTKs that specifically bind to and are activated by collagen, a major protein component of the ECM. Hence, the DDRs are part of the signaling networks that translate information from the ECM, and thus they are key regulators of cell-matrix interactions. Under physiological conditions, DDRs control cell and tissue homeostasis by acting on collagen sensors; transducing signals that regulate cell polarity, tissue morphogenesis, cell differentiation, and collagen deposition. DDRs play a key role in diseases that are characterized by dysfunction of the stromal component, which lead to abnormal collagen deposition and the resulting fibrotic response that disrupt normal organ function in disease of the cardiovascular system, lungs and kidneys, just to mention a few. In cancer, DDRs are hijacked by tumor and stromal cells to disrupt normal cell-collagen communication and initiate pro-oncogenic programs. Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function, and contribute to cancer progression. Therefore, the strong causative association between altered RTK function and disease it is been translated today in the development of specific tyrosine kinase inhibitors targeting DDRs for various disease conditions. In spite of the accumulating evidence highlighting the importance of DDRs in health and diseases, there is still much to learn about these unique RTKs, as of today there is a lack in the medical literature of a book dedicated solely to DDRs. This is the first comprehensive volume dedicated to DDRs, which will fill a gap in the field and serve those interested in the scientific community to learn more about these important receptors in health and disease.
650 0 $a Cell receptors. $3 668471
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Medical Microbiology. $3 668401
650 2 4 $a Medical Biochemistry. $3 668897
650 2 4 $a Cell Biology. $3 593889
700 1 $a Fridman, Rafael. $3 1112151
700 1 $a Huang, Paul H. $3 1112152
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-1-4939-6383-6
950 $a Biomedical and Life Sciences (Springer-11642)